Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Prevention of Osteoporosis in Men With Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Completed
50 to 85
NIDDK
DK61535
NCT00048841
Last Modified:
6/2/2008
 
First Published:
7/14/2006
2.
Phase III Companion Study of Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Treated on Protocol CAN-NCIC-MA27
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Natural history/Epidemiology, Supportive care
Closed
45 and over
NCI
CAN-NCIC-MA27B
NCIC-MA.27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, NCT00354302, MA27B
Last Modified:
10/20/2007
 
First Published:
5/1/1999
3.
Phase II Randomized Study of High-Dose Ketoconazole With or Without Alendronate Sodium in Patients With Androgen-Independent Metastastic Adenocarinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
NCI-99-C-0052
NCT00019695
Last Modified:
1/1/1991
4.
Randomized, Double-Blind, Multicenter Study of a Single Intravenous Dose of MK-217 vs Standard Etidronate Treatment in Patients with Malignancy-Associated Hypercalcemia (Summary Last Modified 01/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
over 18
MSKCC-90117
NCI-V90-0194
Last Modified:
8/1/1991
5.
Open-Label, Multicenter Study of a Single Intravenous Dose of MK-217 in Patients with Malignancy-Associated Hypercalcemia and Moderately Severe Renal Insufficiency (Summary Last Modified 08/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Completed
18 and over
MSKCC-91039
NCI-V91-0105
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute